Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

First-in-human Study to Assess the Clinical Feasibility, Safety, and Performance of the α Prototype of the NIMBLE System for Diagnosing Complications in Intracoronary Stents. NIMBLE-I Study.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06968858
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:49.122752+00:00
Published At
2025-05-13T00:00:00+00:00
Record Updated At
2025-05-13
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["In-stent Restenosis", "Stent Fracture", "Stent Complication"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-05-13"
protocolSection.identificationModule.nctId
"NCT06968858"
protocolSection.identificationModule.officialTitle
"First-in-human Study to Assess the Clinical Feasibility, Safety, and Performance of the \u03b1 Prototype of the NIMBLE System for Diagnosing Complications in Intracoronary Stents. NIMBLE-I Study."
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • In-stent Restenosis (protocolSection.conditionsModule.conditions)
  • Stent Fracture (protocolSection.conditionsModule.conditions)
  • Stent Complication (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.